BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32791747)

  • 1. Identification of key genes and pathways in IgA nephropathy using bioinformatics analysis.
    Hu SL; Wang D; Yuan FL; Lei QF; Zhang Y; Cheng JZ
    Medicine (Baltimore); 2020 Jul; 99(30):e21372. PubMed ID: 32791747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miRNA-mRNA network and immune-related gene signatures in IgA nephropathy by integrated bioinformatics analysis.
    Wei SY; Guo S; Feng B; Ning SW; Du XY
    BMC Nephrol; 2021 Nov; 22(1):392. PubMed ID: 34823491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis reveals novel hub gene pathways associated with IgA nephropathy.
    Jiang X; Xu Z; Du Y; Chen H
    Eur J Med Res; 2020 Sep; 25(1):40. PubMed ID: 32894197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis.
    Noor F; Saleem MH; Aslam MF; Ahmad A; Aslam S
    Saudi J Biol Sci; 2021 Sep; 28(9):4938-4945. PubMed ID: 34466069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis.
    Li X; Zeng M; Liu J; Zhang S; Liu Y; Zhao Y; Wei C; Yang K; Huang Y; Zhang L; Xiao L
    BMC Med Genomics; 2023 Mar; 16(1):63. PubMed ID: 36978098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of glomerulotubular crosstalk genes mediating IgA nephropathy by integrated bioinformatics.
    Bai Y; Li Y; Xi Y; Ma C
    BMC Nephrol; 2022 Apr; 23(1):143. PubMed ID: 35418061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Bioinformatics Analysis of IgA Nephropathy Gene Based on GEO Databases.
    Qian W; Xiaoyi W; Zi Y
    Biomed Res Int; 2019; 2019():8794013. PubMed ID: 31392215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis reveals novel hub genes closely associated with pathological mechanisms of immunoglobulin A nephropathy.
    Zhang D; Cao Y; Zuo Y; Wang Z; Mi X; Tang W
    Exp Ther Med; 2019 Aug; 18(2):1235-1245. PubMed ID: 31316619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation.
    Xia M; Liu D; Liu H; Peng L; Yang D; Tang C; Chen G; Liu Y; Liu H
    Front Med (Lausanne); 2022; 9():881322. PubMed ID: 35836957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Prognostic Biomarkers Specifically Expressed in Macrophage in IgA Nephropathy Patients Based on Integrated Bioinformatics Analyses.
    Ding Y; Li H; Xu L; Wang Y; Yang H
    Front Mol Biosci; 2022; 9():884588. PubMed ID: 35601837
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of key genes, pathways and potential therapeutic agents for IgA nephropathy using an integrated bioinformatics analysis.
    Chen X; Sun M
    J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320919635. PubMed ID: 32370650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane signaling molecules play a key role in the pathogenesis of IgA nephropathy: a weighted gene co-expression network analysis study.
    Gholaminejad A; Roointan A; Gheisari Y
    BMC Immunol; 2021 Dec; 22(1):73. PubMed ID: 34861820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key candidate genes for IgA nephropathy using machine learning and statistics based bioinformatics models.
    Al Mehedi Hasan M; Maniruzzaman M; Shin J
    Sci Rep; 2022 Aug; 12(1):13963. PubMed ID: 35978028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy.
    Liu Y; Liu X; Jia J; Zheng J; Yan T
    J Transl Med; 2019 Sep; 17(1):320. PubMed ID: 31547815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CCL2, FOS, and JUN May Help to Distinguish Patients With IgA Nephropathy From Healthy Controls.
    Zhou X; Wang N; Zhang Y; Yu P
    Front Physiol; 2022; 13():840890. PubMed ID: 35464092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic analysis reveals the potential crosstalk genes and immune relationship between IgA nephropathy and periodontitis.
    Gao X; Guo Z; Wang P; Liu Z; Wang Z
    Front Immunol; 2023; 14():1062590. PubMed ID: 36793719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis.
    Gan T; Qu LX; Qu S; Qi YY; Zhang YM; Wang YN; Li Y; Liu LJ; Shi SF; Lv JC; Zhang H; Peng YJ; Zhou XJ
    Int Immunopharmacol; 2024 May; 132():111905. PubMed ID: 38552291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
    Xie R; Li B; Jia L; Li Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of molecular mechanisms underlying the therapeutic effects of Celosia Cristata on immunoglobulin nephropathy.
    Rehman A; Noor F; Fatima I; Qasim M; Liao M
    Comput Biol Med; 2022 Dec; 151(Pt A):106290. PubMed ID: 36379189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.